The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study

Table 3 Univariable and multivariable Cox regression analysis for developing ASB within one year after transplantation according to TMP-SMX prophylaxis administration

	Outcome ASB	P value
	HR (95 % CI)	P value
TMP-SMX: univariable model (a)	2.03 (1.17–3.55)	0.012
TMP-SMX: first multivariable model (b)	1.18 (0.63–2.20)	0.600
TMP-SMX: second multivariable model (c)	1.52 (0.79–2.94)	0.213

a: Univariable model: adjusted for only TMP-SMX use
b: First multivariable analysis: adjusted for diabetes mellitus, subtype of immunosuppressive therapy and indwelling urological catheters
c: Second multivariable analysis: adjusted for diabetes mellitus, subtype of immunosuppressive therapy, indwelling urological catheters, age of recipient and donor and female gender

ISSN: 1471-2334